Purchase Order 75N91021P00726
- Not listed
- The National Cancer Institute awarded a firm fixed-price purchase order valued at $402,725 to Leica Microsystems Inc. (through its Leica Biosystems division) for maintenance services on specialized confocal microscopy equipment supporting the Thoracic and GI Malignancies Branch. The contract covers preventative maintenance, on-site emergency repairs, software support, and parts replacement for two government-owned instruments: a Leica Basic Module TCS SP8 LIAchroic IR microscope and a Leica...
- The National Cancer Institute awarded a $45,624.80 firm fixed-price purchase order to Leica Microsystems Inc. on April 27, 2026, for comprehensive maintenance and repair services on a Leica Stellaris 8 FLIM confocal microscope located at the NCI CCR Microscopy Core in Bethesda, Maryland. The 12-month contract, which extends through April 26, 2027, requires Leica to provide unlimited on-site repairs, replacement parts, one preventative maintenance inspection, firmware and software updates, and...
- The National Cancer Institute (NCI) awarded a $158,311 firm fixed price purchase order to Leica Microsystems Inc. for annual service maintenance of a Leica SP8 WLL confocal scanning microscope with Falcon module located at the Laboratory of Cell and Molecular Biology (LCMB) in Bethesda, Maryland. The award, issued on March 1, 2026, was issued without set-aside designation and will extend through February 28, 2029. The contract encompasses preventive maintenance services including equipment...
- The National Cancer Institute (NCI), an agency within the National Institutes of Health, awarded a $545,992.04 firm fixed-price purchase order to Leica Microsystems Inc. (Leica Biosystems division) on March 27, 2025, for preventative maintenance and emergency repair services for three government-owned Leica imaging devices supporting cancer research at the Center for Cancer Research in Bethesda, Maryland. The devices include a Leica Stellaris 5 confocal microscope, a Leica CellDIVE microscope,...
- This firm fixed-price purchase order was awarded by the National Cancer Institute (NCI), a component of the Department of Health and Human Services (HHS), to Leica Microsystems Inc. for maintenance services on a government-owned Leica SP8 WLL2 TAN laser scanning confocal microscope. The $169,050.00 contract has a performance period through September 6, 2026. Leica is the original equipment manufacturer for this specialized microscope system and was determined to be the sole source capable of...
- The National Cancer Institute awarded a $202,490.42 firm fixed price purchase order to Leica Microsystems Inc. (Leica Biosystems division) on June 13, 2024, for preventive maintenance services on one Leica Stellaris microscope under a Premium Care service agreement. The contract extends through June 12, 2029, and will be performed at Leica's facility in Riverwoods, Illinois. No small business set-aside designation was used in this competitive award to the original equipment manufacturer,...
- This is a firm fixed-price purchase order awarded by the National Cancer Institute (NCI), which is part of the Department of Health and Human Services, to Leica Microsystems Inc. for a Leica TCS SP8 Spectral Confocal and MP System. The total ceiling value of the contract is $585,191.25, and the ultimate completion date is December 15, 2016. The contract was awarded on September 16, 2016 and did not have a set-aside designation. Leica Microsystems Inc. is a manufacturer of microscopes, scientific...
- This is a $10,158.72 firm fixed-price purchase order awarded by the National Cancer Institute to Leica Microsystems Inc., a for-profit manufacturer of specialized microscopes, scientific instruments, and imaging equipment. The contract is for a maintenance agreement on Leica's advanced microscopy products, including Stellaris confocal microscopes, Aperio digital slide scanners, and other imaging platforms. Leica Microsystems has established itself as a critical vendor for scientific research,...
- This is a firm fixed-price purchase order contract awarded by the National Cancer Institute (NCI), part of the U.S. Department of Health and Human Services, to Leica Microsystems Inc. for software license, maintenance, and support for a government-owned Leica Microsystems AT2 ScanScope digital slide scanner and image analysis system. The contract has a ceiling value of $121,265.98 and a period of performance ending on September 28, 2019. Leica Microsystems Inc. is a subsidiary of the Danaher...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm-fixed price purchase order valued at approximately $945,000 to Leica Microsystems Inc. Leica Biosystems Division. The contract is for the acquisition of one Leica Stellaris 8 confocal and CARS (Coherent Anti-Stokes Raman Spectroscopy) and SRS (Stimulated Raman Spectroscopy) microscope to support research at the National Cancer Institute's Center for Cancer Research Neuro-Oncology...
Leica Microsystems Inc. (Leica Biosystems division) received a $67,801.53 firm fixed-price purchase order from the National Cancer Institute (NCI) to provide maintenance services for two advanced confocal microscope systems: one Leica Basic Module TCS SP8 with LiaChroic and one Leica White Light Laser TCS SP8 X Falcon DMI8 WLL. These systems are located within NCI's Center for Cancer Research (CCR) Tumor Growth Microenvironment Branch (TGMB) laboratory in Bethesda, Maryland. The contract was awarded on September 8, 2021, with an ultimate completion date of September 7, 2022. No set-aside designation was used in this award, indicating open competition among qualified vendors. This purchase order was established to administratively de-obligate unexpended and expiring Fiscal Year 2021 funding in accordance with 31 U.S.C. Section 1552(a), in preparation for the September 30, 2026 closing of the period of availability for these fiscal year funds. As the original equipment manufacturer of these specialized confocal microscopy systems, Leica Microsystems is well-positioned to provide comprehensive maintenance support, ensuring operational continuity of critical imaging infrastructure supporting the NCI's cancer research initiatives. Leica maintains an established relationship with the National Institutes of Health and its constituent institutes through multiple prime contracts and indefinite delivery vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Funding Only Action | 0$ | 3/15/26 | |
| P00002 | Other Administrative Action | $0 | 2/9/22 | |
| P00001 | Other Administrative Action | $0 | 11/22/21 | |
| Not listed | Not listed | $67.8k | 9/8/21 |